AKT1 and thyroid gland undifferentiated (anaplastic) carcinoma: Thus, phosphorylation and O-GlcNAcylation together may regulate PI3K/Akt signaling, and drugs targeted to affect this pathway may be useful for the treatment of thyroid anaplastic cancer.